XORTX Therapeutics (XRTX) Notes Payables (2021 - 2026)
XORTX Therapeutics (XRTX) posted Notes Payables of $1000.0 for Q1 2026, down 87.5% on a QoQ basis from $8000.0 in Q4 2025, and down 99.69% year-over-year from $326000.0 in Q1 2025.
XORTX Therapeutics (XRTX) Notes Payables (2021 - 2026) Analysis & Trends
XORTX Therapeutics' Notes Payables history runs 6 years deep, the most recent figure standing at $1000.0 for Q1 2026.
- Quarterly Notes Payables fell 99.69% year-over-year to $1000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1000.0 (down 99.69% YoY) and the FY2025 annual result came in at $8000.0, down 98.6% from the prior year.
- Notes Payables was $1000.0 for Q1 2026 at XORTX Therapeutics, down from $8000.0 in the prior quarter.
- Across five years, Notes Payables topped out at $3.8 million in Q4 2022 and bottomed at $1000.0 in Q1 2026.
- A 5-year average of $1.3 million and a median of $950500.0 in 2024 frame the typical range for Notes Payables.
- Annual changes were most pronounced in 2024 — Notes Payables rose 7.72% — and 2026, when it slumped 99.69%.
- XORTX Therapeutics' Notes Payables stood at $3.8 million in 2022, then plunged by 86.19% to $531000.0 in 2023, then advanced by 7.72% to $572000.0 in 2024, then plunged by 98.6% to $8000.0 in 2025, then sank by 87.5% to $1000.0 in 2026.
- Business Quant data shows XRTX's Notes Payables at $1000.0 in Q1 2026, $8000.0 in Q4 2025, and $101000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | XORTX Therapeutics | 20.40 Mn | 20.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,000.00 |
| Dec 31, 2025 | 8,000.00 |
| Sep 30, 2025 | 101,000.00 |
| Jun 30, 2025 | 177,000.00 |
| Mar 31, 2025 | 326,000.00 |
| Dec 31, 2024 | 572,000.00 |
| Sep 30, 2024 | 1.33 Mn |
| Jun 30, 2024 | 1.57 Mn |
| Mar 31, 2024 | 3.22 Mn |
| Dec 31, 2023 | 531,000.00 |
| Dec 31, 2022 | 3.85 Mn |
| Sep 30, 2022 | 1.74 Mn |
| Jun 30, 2022 | 2.15 Mn |
| Mar 31, 2022 | 3.30 Mn |
| Dec 31, 2021 | 3.65 Mn |
| Sep 30, 2021 | 9.02 Mn |